Beta Drugs share news, announcements and annual reports
NSE: BETAPharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,849.70.
30 Oct: open ₹1,880.60, high ₹1,880.60, low ₹1,790.60
- Under NSE's long-term additional surveillance, stage I, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹2,000 Cr1,305th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 36.99
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.57
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 16.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 14.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.10
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 23,66047.9% delivered
Beta Drugs share news and announcements
387 announcements, routine notices left out, newest first. Page 7 of 8.
Jul 2019
27 Jul · Board meeting
11 Jul · Changes in Shareholding
3 Jul · Changes in Shareholding
1 Jul · Board meeting
Jun 2019
May 2019
29 May · Board meeting
20 May · Related Party Transactions
13 May · Board meeting
13 May · Results
13 May · Board meeting
4 May · Board meeting
1 May · Board meeting
1 May · Board meeting
Apr 2019
26 Apr · Board meeting
24 Apr · Analysts
Mar 2019
28 Mar · Board meeting
25 Mar · Business
25 Mar · Board meeting
23 Mar · Board meeting
12 Mar · Updates
Feb 2019
4 Feb · Board meeting
Jan 2019
31 Jan · Updates
30 Jan · Board meeting
24 Jan · Analysts
Dec 2018
27 Dec · Analysts
12 Dec · Board meeting
8 Dec · Board meeting
6 Dec · Analysts
3 Dec · Changes in Shareholding
Nov 2018
Oct 2018
26 Oct · Results
26 Oct · Board meeting